# Tailoring Maintenance Therapy to Cluster of Differentiation 5 Positive (CD5+) Regulatory B Cell Recovery in ANCA Vasculitis

> **NCT03906227** · NA · TERMINATED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 9 (actual)

## Conditions studied

- ANCA Associated Vasculitis

## Interventions

- **DEVICE:** ENUMERATION OF CD5+ B Cells

## Key facts

- **NCT ID:** NCT03906227
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-06-28
- **Primary completion:** 2025-02-27
- **Final completion:** 2025-02-27
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Study recruitment terminated due to lack of funding.
- **Last updated:** 2025-11-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03906227

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03906227, "Tailoring Maintenance Therapy to Cluster of Differentiation 5 Positive (CD5+) Regulatory B Cell Recovery in ANCA Vasculitis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03906227. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*